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Peripheral regulatory T cells from silicosis patients are susceptible to 
CD95-mediated apoptosis
Hiroaki HAYASHI
Department of Hygiene, Kawasaki Medical School, 577 Matsushima Kurashiki, 701-0192, Japan
ABSTRACT  Given that silicosis patients (SILs) suffer not only from pulmonary fibrosis but 
also from complications associated with autoimmune diseases such as rheumatoid arthritis and 
systemic sclerosis, silica may have the effect of disturbing self-tolerance.  One advancement in 
the field of immunoregulation concerned discovery of the regulatory T (Treg) cell, characterized 
as CD4+CD25+ and FoxP3+.  Treg cells regulate the activation of responder T cells, and 
a reduction in the size (absolute and/or relative number) and function of Treg cells leads to 
excessive activation of responder T cells against various antigens including self-antigens. 
This mechanism may be associated with the occurrence of autoimmune diseases.  Our 
previous investigations showing reduced Treg cell function in the CD4+CD25+ fraction of SILs 
indicated alterations of Treg cell size or function.  Here, we examined the expression of pd-
1, a T cell activation marker, in CD4+CD25- and CD4+CD25+ fractions, expression of surface 
CD95 known as Fas, an apoptosis inducing receptor, in Treg cells, and susceptibility against 
apoptosis inducing anti-CD95 antibody in CD4+CD25- and CD4+CD25+ cells.  We observed 
chronic activation of responder T and Treg cells in SILs, higher expression of CD95 and higher 
susceptibility to the CD95 stimulating antibody in Treg cells from SILs.  Taken together, the 
reduction of Treg cell function and size caused by excessive loss of Treg cells and substitution 
by chronically activated responder T cells caused by silica exposure may be important in 
facilitating the disturbance of autoimmunity in SILs.
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InTRoDuCTIon
   Silicosis is defined by chronic and progressive 
pulmonary fibrosis caused by occupational 
inhalation of small silica particles. Silicosis patients 
(SILs) suffer from respiratory dysfunction and 
pulmonary complications such as tuberculosis, 
chronic bronchitis and emphysema1‒3).  Additionally, 
SILs often have complications associated with 
autoimmune diseases such as rheumatoid arthritis 
4‒6) (known as Caplan syndrome) and systemic 
sclerosis7‒9).  The effects of silica on autoimmunity 
have also been recognized following the observation 
that patients who receive plastic surgery with 
implants containing silicone ([SiO2-O-]n) show 
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frequent complications involving autoimmune 
disorders10,11). These findings clearly indicate 
that crystalline silica causes dysregulation and/or 
disturbance of the human immune system.
   One recent immunological finding relates to the 
discovery of CD4+CD25bright and transcription 
factor forkhead box P3 (foxp3) gene expressing 
regulatory T (Treg) cells, and that Treg cells 
contribute to maintaining self-tolerance by 
down-regulating immune responses to self and 
non-self antigens (Ags) in an Ag-non-specific 
manner, presumably at the T cell activation stage; 
elimination/reduction of CD4+CD25bright T cells 
relieves this general suppression, thereby not only 
enhancing immune responses to non-self Ags, but 
also eliciting autoimmune responses to certain self-
Ags.  Genetic anomalies of foxp3 cause autoimmune 
and inflammatory disease in rodents and humans 
by affecting the development and function of 
CD4+CD25bright Treg cells12‒14). 
   It is known that Treg cells suppress the activation 
of responder T cells against foreign and self 
antigens.  Thus, deficiencies in Treg cell function 
or decreases in the proportion/size of Treg cells 
have been observed to influence the pathogenesis of 
collagen or autoimmune diseases such as multiple 
sclerosis15), rheumatoid arthritis16), systemic lupus 
erythematosus17), and pemphigus vulgaris18). 
   Our group has investigated alterations of the 
immune system in SILs, with a focus on CD95 
(also known as Fas), an apoptotic cell death 
inducing receptor19‒21).  Our findings showed that 
SILs exhibited elevated serum soluble Fas levels22), 
increased relative expression of soluble fas and 
dcr3 genes in peripheral blood mononuclear 
cells23,24), high levels of other variant messages of 
fas transcripts25), relatively decreased expression 
of genes encoding several physiological inhibitors 
(such as surviving and  toso)26), and a predominance 
of lower-membrane Fas expression in lymphocytes, 
which predominantly transcribe soluble fas, 
compared with soluble Fas transcript in healthy 
donors (HDs)21).  The CD95 receptor has been 
implicated in controlling T cell expansion by 
triggering T cell-autonomous apoptosis.  CD95-
dependent elimination is a major regulatory 
mechanism in autoimmune responses and acts 
in concert with the CD95-mediated regulation of 
chronically activated autoimmune T cells.  Thus, 
various alterations of CD95-related molecules may 
be a manifestation of impaired autoimmunity in 
SILs.
   Additionally, we previously reported on the 
reduced function of the CD4+CD25+ regulatory T 
cell fraction in SILs27) and the in vitro activation of 
responder T cells by silica particles28).
   In this study, given our previous findings which 
showed several alterations in lymphocytes or T 
cells from SILs, we attempt to confirm that silica 
exposure is the environmental factor which leads to 
the dysregulation of autoimmunity19-21). 
MATeRIAlS  AnD  MeThoDS
Isolation of human peripheral blood mononuclear 
cells (PBMCs) and patients studied
   PBMCs were isolated from heparinized peripheral 
blood of healthy donors (HDs: n=4 age 35±11) 
and SILs(n=8 age 73±6.8) using a Ficoll-Hypaque 
density gradient. Specimens were taken from HDs 
and SILs from whom informed consent had been 
obtained. The Institutional Ethics Committee of 
Kawasaki Medical School, Kusaka Hospital and 
Urakami Iin had approved the project. All SILs 
were brickyard workers in Bizen City, Okayama 
Prefecture, Japan, and were followed at Kusaka 
Hospital and Urakami Iin, and the substances 
which these SILs had been handled were estimated 
to include as high as 40 to 60% of free silica. The 
subjects were diagnosed with pneumoconiosis 
according to the ILO 2000 guideline29). They showed 
no clinical symptoms of autoimmune diseases 
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including sclerotic skin, Raynaud's phenomenon, 
facial erythema or arthralgia.
Cell staining and flow cytometry
   PBMCs were stained with anti-CD4 PE or 
ant i-CD4  FITC or ant i-CD4  PE-Cy7 ,  ant i-
CD25  FITC or anti-CD25-allophycocyanin, 
anti-CD95-allophycocyanin (BD Pharmingen). 
For the intracellular staining of Foxp3, surface 
staining was first performed; cells were fixed and 
permeabilized, and then incubated with anti-FoxP3-
PE (eBioscience) using an anti-human regulatory 
T cell staining kit (eBioscience) according to the 
manufacturer's instructions. Cells were sorted using 
a FACSariaTM flow cytometer (BD Bioscience) 
and analyzed with FACS-Diva software (BD 
Bioscience). The CD25bright gate was adjusted to less 
than 1~3% in CD4+ T cells and the CD25+ gate was 
greater than the CD25 bright zone in several HDs, 
and previously reported27). 
Gene expression in responder T (Tres) cells and 
Treg fractions from HDs and SILs. 
      RNA extraction, cDNA synthesis and real-time 
reverse transcription-polymerase chain reaction 
(RT-PCR) with SYBR-G using Tres and Treg cells 
from HDs and SILs were performed as previously 
reported21). The relative expression levels of pd-1 
and gapdh were examined with a fluorescence 
thermocycler  (Mx3000P®  QPCR Sys tem, 
Stratagene Corporation, La Jolla, CA) using the 
following primer sets: 
pd-1: (forward: GTGTCACACAACTGCCCAAC, 
reverse: CTGCCCTTCTCTCTGTCACC, 162 bp ),
Gapdh: (forward: GAGTCAACCGATTTGGTCGT, 
reverse: TTGATTTTGGAGGGATCTCG, 238 bp).
   The relative expression of the pd-1 gene was 
calculated as follows:
A:  number of PCR cycles required to reach a 
certain level of fluorescence for the gapdh product.
B:  number of PCR cycles required to reach the 
same level of fluorescence for the pd-1 gene derived 
from the same samples. 
   The relative expression of the pd-1 gene is given 
by 1/2[B-A] with the gapdh expression being 1.0. 
Real-time RT-PCR products were assessed by 
standard agarose gel electrophoresis and staining 
with ethidium bromide.
Cell culture and apoptosis assay
   Apoptosis was analyzed by staining cells with 
FITC-annexin V and propidium iodide (PI) 
(Roche, Basel, Switzerland) according to the 
manufacturer's instructions. Finally, the percentages 
of annexin V-positive PI-negative cells and annexin 
V-positive and PI-positive cells were measured 
using a FACSCaliburTM (Becton Dickinson) flow 
cytometer. Specific cell death was calculated as 
follows; (percent of experimental cell death - 
percent of spontaneous cell death)/ (100-percent of 
spontaneous cell death)×100. 
Statistical analysis
   Differences in pd-1 mRNA expression, the mean 
fluorescence intensity (MFI) of surface CD95, and 
the percentage of apoptosis induced by apoptosis-
inducing anti-CD95  Ab (CH11  clone) were 
examined using the nonparametric Mann-Whitney 
U test. Statistical analysis was performed using 
StatView 5.0J  software (SAS Institute, Cary, NC).
ReSulTS
Peripheral CD4+25+ and CD4+25- fractions from 
SILs are chronically activated.
   It was recently revealed that CD4+CD25bright 
Foxp3+ T cells did not exhibit significant levels 
of PD-130), which is known as the inhibitory 
receptor molecule of programmed cell death and 
is upregulated on activated Tres cells. Therefore, 
the PD-1 molecule/gene could be utilized to 
discriminate CD4+CD25+ resting T cells from 
activated T cells. We measured the expression levels 
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of pd-1 using real-time PCR. pd-1 gene expression 
levels in CD4+CD25+ and CD4+CD25- fractions 
were very low in HDs and high SILs, as shown 
in Fig. 1.  These results supported our previous 
experimental finding which suggested that silica 
can stimulate Tres cells, and that activated T cells 
present in the CD4+CD25+ fraction from SILs, in 
addition to the CD4+CD25+ fraction, may include 
activated Tres and activated Treg cells.
CD95 is highly expressed in Treg cells from SILs but 
not from HDs
   The surface expression of CD95 in Treg cells has 
recently been investigated, and these cells seemed 
to show higher expression of CD95 and a tendency 
to progress towards apoptosis31‒33). CD4+FoxP3+ 
T cells represent only a minor population (less 
than 5%) of peripheral blood CD4+ T cells (Fig. 
2).  Statistically, the MFI of Fas molecules in 
Fig. 1. The relative expression levels of pd-1 in CD4+CD25- 
and CD4+CD25+ fractions from HDs (healthy donors) and 
SILs (silicosis patients).  The pd-1 gene, a marker gene for 
activated T cells, was overexpressed in the CD4+CD25+ 
fraction of SILs but not in HDs.  Both CD4+CD25- and 
CD4+CD25+ fractions from SILs showed higher expression 
of pd-1 compared those from HDs. 
Fig. 2. Expression levels of CD95 in CD4+FoxP3+ and CD4+FoxP3- T cells. Representative CD4+FoxP3+ 
T cells in PBMCs from HDs revealed a CD4+ fraction of 3.6% (panel A). Representative surface CD95 
expression in peripheral CD4+FoxP3+ cells from HDs (panel B) and CD4+FoxP3- cells from HDs (panel C). 
The CD95 expression is higher in CD4+FoxP3+ cells compared with CD4+25- cells. 
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CD4+FoxP3+ cells was significantly up-regulated in 
SILs compared with that in HDs (Fig. 3). These data 
indicated that Treg cells in SILs are activated by 
chronic low-dose and long-term exposure to silica, 
since Fas is known as one of the activated markers 
of Treg cells.
CD4+CD25+ Treg cells from SILs were more 
sensitive to anti-CD95 Ab-induced apoptosis 
compared with cells from HDs.
   In an effort to determine whether freshly isolated 
Treg cells from SILs are sensitive to CD95-
mediated apoptosis, FACSAria-sorted Treg and 
Tres cells were cultured with anti-CD95 Ab (anti-
APO-1) for six and twelve hours.  As shown in 
Fig. 4, T cells from CD4+CD25+ fractions derived 
from both HDs and SILs showed a time-dependent 
Fig. 4. In vitro silica-induced speciﬁc cell death in Tres and Treg from HDs or SILs. CD4+CD25- and CD4+CD25+ cells 
from SILs (n=8) and HDs (n=4) were cultured with apoptosis-inducing anti-CD95 Ab for six and twelve hours. Apoptotic 
cells were deﬁned as Annexin V+ and PI-. Upper panels show actual changes in apoptotic cells of the CD4+CD25- 
(square) and CD4+CD25+ (diamond) fractions from HDs (left) and SILs (right).  Lower panels show speciﬁc cell death 
calculated using the formula shown in the ﬁgure.  There is a signiﬁcant increase in speciﬁc apoptosis in CD4+CD25+ 
cells when cells from SILs were cultured for six and twelve hours, and in cells from HDs cultured for twelve hours.
Fig. 3. Comparison of the MFI of Fas on CD4+FoxP3- or 
CD4+FoxP3+ cells from fourteen HDs and twenty-one SILs. 
Signiﬁcant differences are shown with asterisks (*p < 0.05).
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increase in apoptotic cells defined by annexin+ and 
PI-, although CD4+CD25- cells from both HDs and 
SILs did not show any increase in apoptotic cells.
   The specific cell death (%) was defined as shown 
in Fig. 4.  This relates only to the percentage of cell 
death caused by anti-CD95 Ab.  The appearance of 
apoptotic cells gradually increased in CD4+CD25+ 
cells from both HDs and SILs, and at twelve hours 
incubation the specific cell death in CD4+CD25+ 
cells from HDs and SILs were significantly higher 
compared with CD4+CD25- cells.  However, at 
six hours incubation only CD4+CD25+ cells from 
SILs showed a significant increase in the number of 
apoptotic cells.  This may suggest that CD4+CD25+ 
cells from SILs were susceptible to CD95-mediated 
apoptosis.
   The specific cell death of CD4+CD25+ cells from 
both HDs and SILs with apoptosis-inducing anti-
CD95 Ab at six hours incubation is shown in Fig. 
5.  Unlike the case with HDs, a significant increase 
in apoptosis of CD4+CD25+ cells from SILs was 
clearly evident.  This indicates that CD4+CD25+ 
cells from SILs were susceptible to CD95-mediated 
apoptosis.
DISCuSSIon
   Our previous data showed that Treg cell function 
of the CD4+CD25+ fraction from SILs was reduced, 
whereas the size of CD4+CD25+ cells did not differ 
markedly from that of HDs27).  Additionally, we 
showed that silica could activate peripheral blood 
T lymphocytes in vitro as monitored by CD69, 
an early activation marker of T cells28).  Thus, our 
previous finding concerning the reduction of Treg 
cell function in SILs involved contamination by 
chronically activated Tres cells in the CD4+CD25+ 
fraction, since it is well known that activated T 
cells express CD25 on their surface.  However, 
if contamination by activated Tres cells in the 
CD4+CD25+ fraction had only occurred, the size 
of the CD4+CD25+ fraction should have increased, 
and since activated Treg cells were present in this 
fraction, normal Treg cells should also have been 
present.  Consequently, the total Treg function of the 
CD4+CD25+ fraction in SILs may not be altered.
   Thus,  a loss of true Treg cells  from the 
CD4+CD25+ fraction in SILs is required for there 
to be no change in the size of CD4+CD25+ cells and 
reduction of Treg cells in SILs.  The investigation 
then shifted focus to the CD95, since we previously 
demonstrated various alterations in CD95 and a 
CD95-related molecule in SILs19‒26).
   The surface expression of CD95 in Treg cells 
has recently been investigated, and these cells 
seemed to show higher expression of CD95 and 
a tendency to progress towards apoptosis31‒33). 
Similarly, the results of this study also showed that 
CD95 was more highly expressed in Treg cells 
(CD4+CD25+FoxP3+ cells) from SILs and HDs 
compared with that expression observed in Tres 
cells.  Additionally, CD95 expression in Treg cells 
from SILs was significantly higher compared with 
Fig. 5. The comparison of silica-induced speciﬁc cell death 
of Treg derived from HDs or SILs.  Statistically, the speciﬁc 
apoptosis deﬁned in Fig. 4 in CD4+CD25+ cells from SILs 
cultured with anti-CD95 Ab for six hours was higher than that 
in cells from HDs.
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that of HDs.  This may be the result of chronic 
activation of Treg cells by silica exposure.  
   The susceptibility of Treg cells from SILs was 
also upregulated compared than that from HDs, 
particularly in the early phase of cultivation with 
apoptosis-inducing anti-CD95 Ab in vitro. Thus, this 
may represent one mechanism which leads to early 
loss of Treg cells from the CD4+CD25+ fraction in 
SILs.
   The effects of chronic silica exposure are outlined 
in Fig. 6.  Chronic silica exposure induces chronic 
activation of both Tres and Treg cells.  Activated 
Tres cells begin to express CD25 and are then 
present in the CD4+CD25+ fraction, which 
predominantly comprises Treg cells without any 
stimulation.  Additionally, activated Treg cells then 
begin to express CD95 cell death receptor, progress 
towards apoptosis, and are then absent from the 
CD4+CD25+ fraction.  Thus, as reported previously, 
the CD4+CD25+ fraction in SILs showed no 
marked changes in size, but possessed reduced 
function.
   Fu r the r  i nves t iga t ions  a r e  r equ i r ed  to 
determine whether the number of true Treg 
cells (CD4+CD25+FoxP3+) are reduced in the 
CD4+CD25+ fraction of SILs (previously we 
only examined the number of CD4+CD25+ cells), 
whether CD95-neutralizing Ab can rescue CD95-
mediated apoptosis in Treg cells from HDs and 
SILs, and the outcome of re-stimulating Treg cells 
from SILs with silica in vitro.
   In conclusion, it is clear that occupational exposure 
can influence the development and course of 
autoimmune disease.  Silica may act as an adjuvant, 
enhance the immune response, modify apoptosis to 
self-reactivity, or induce regulatory mechanisms. 
These mechanisms may be relevant with respect 
to the onset of autoimmune and collagen diseases. 
Fig. 6. Schematic presentation of the mechanisms involved that lead to a reduction of Treg function and size in SILs. 
Chronic exposure to silica causes activation of Tres and Treg cells.  Activated Tres cells express CD25 and are present 
in the CD4+CD25+ fraction, where Treg cells are also present if there is no chronic stimulation such as silica exposure. 
Activated Treg cells express CD95 and then become susceptible to CD95-mediated apoptosis, leading to their absence 
from the CD4+CD25+ fraction.  Taken together, Treg cell function and size in the CD4+CD25+ fraction from SILs are 
reduced, and may cause impairment of autoimmunity.
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Therefore, further investigations concerning the 
immunological effects of silica are necessary in an 
effort to delineate the pathophysiology of many 
autoimmune diseases.  
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